The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksJames Fisher and Sons Regulatory News (FSJ)

Share Price Information for James Fisher and Sons (FSJ)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 272.00
Bid: 274.00
Ask: 278.00
Change: -7.00 (-2.51%)
Spread: 4.00 (1.46%)
Open: 273.00
High: 279.00
Low: 272.00
Prev. Close: 279.00
FSJ Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sale of JFN, Trading Update and Notice of Results

6 Mar 2023 07:00

RNS Number : 9282R
Fisher (James) & Sons plc
06 March 2023
 

This announcement contains inside information

6 March 2023

James Fisher and Sons plc

Sale of JFN, Trading Update and Notice of Results Announcement

 

James Fisher and Sons plc (FSJ.L) ('James Fisher', 'the Group'), the leading provider of marine services, announces that it has sold the entire issued share capital of James Fisher Nuclear Holdings Limited and related properties ("JFN", "the business"), to Myneration Limited, a wholly-owned investment vehicle of Rcapital Partners LLP ("Rcapital").

 

The sale forms part of the Board's ongoing commitment to rationalise and focus the Group's portfolio. Existing management and staff will remain with the business as it transitions into new ownership and Rcapital will provide JFN with a £3m secured revolving credit facility to fund the growth of the business going forward.

 

The Group has historically given a number of parent company guarantees to support the obligations of JFN. These guarantees will remain with James Fisher following completion of the transaction although certain limited counter-indemnities have been put in place. The Group has also received certain limited undertakings and information rights in respect of the principal parent company guarantee remaining in place following completion.

 

Following completion, an unsecured loan of £1.2m which has been made available by the Group to JFN will remain outstanding. It is anticipated that the amount outstanding under that loan will be repaid by JFN shortly after completion. In addition, the Group will make a secured interest-bearing term loan facility of up to £3.5m available to JFN. The Group has also entered into an inter-creditor agreement which sets out the priority of the facilities made available to JFN by Rcapital and the Group.

 

JFN is a supplier of specialist engineering, manufacturing and technical services to the UK's nuclear decommissioning industry. The results of JFN have historically been reported within the Specialist Technical division. The results of JFN will be shown as a Discontinued Operation in the Group's 2022 financial statements. In 2021, the business generated third party revenue of £51.7m and a loss before tax of £0.1m. At 30 June 2022 the unaudited gross assets of the business were approximately £36.4m and its net assets were approximately £17.5m, of which Goodwill represented £8.1m. The Group will sell its interest in James Fisher Nuclear Holdings Limited and certain group companies will sell their interests in the related properties for a nominal consideration of £3. As a result of the transaction the Group will impair the value of goodwill and tangible fixed assets associated with the business in its results for the year ended 31 December 2022.

 

Commenting on the sale, Chief Executive Officer, Jean Vernet, said:

"The sale of JFN is a further step in the implementation of our strategy to rationalise and focus the portfolio and, taken together, the business and asset disposals made over the last three months are important steps in streamlining the Group's operations and strengthening the balance sheet. JFN has some valuable and unique capabilities and requires the right investment to exploit the market opportunities in front of it. In Rcapital we are pleased to have found the right owner for the next chapter in this business's development. We wish the business and its employees every future success."

 

Josie Richardson, Investment Director at Rcapital, added:

"JFN plays a crucial role in the UK's nuclear decommissioning industry and, hence, the delivery of the Government's strategic energy plan. Its management team, market-leading technical services and unique UK-based experience in specialist fields put it in a strong position. We are pleased to have the opportunity to support the business as it enters a new phase of growth and development."

 

Trading update for the year ended 31 December 2022

The Group made good strategic and financial progress during 2022, disposing of three businesses, agreeing the sale of the Swordfish dive support vessel and generating good revenue and underlying operating profit growth across the Marine Support, Offshore Oil and Tankships divisions. The Specialist Technical division experienced a disappointing year, with JFD at a trough in its long-term projects cycle and JFN, which will be reported as a Discontinued Operation, reporting an operating loss following ongoing project challenges.

 

For the year ended 31 December 2022, the Group is expecting to report revenue from continuing operations of c.£475m (2021: £442.4m). Underlying operating profit from continuing operations is anticipated to be in line with 2021.

 

The three business sales completed in December 2022 generated gross proceeds of c.£18.4m. Net bank borrowings at 31 December 2022 were c.£135m, with the Group expecting to remain within its banking covenants. The sale of the Swordfish Dive Support Vessel, which was announced in December 2022, completed in January 2023, with cash proceeds of c.£20m now received. The Group has commenced discussions with its lending group regarding existing borrowing facilities, which have maturity dates ranging from October 2023 to September 2024.

Notice of Results Announcement

The Group's full year results will be published on 28 March 2023, two weeks later than had originally been planned, reflecting the significantly higher-than-normal levels of recent corporate activity and consequential impact on audit timetable.

 

 

 

For further information:

James Fisher and Sons plc

Jean Vernet

Duncan Kennedy

Chief Executive Officer

Chief Financial Officer

020 7614 9500

FTI Consulting

Richard Mountain

Susanne Yule

0203 727 1340

 

 

The person responsible for making this announcement on behalf of the Company is Jean-François Bauer, Group General Counsel.

 

LEI: 213800J975E5OYR6S216

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSSIEEIEDSEFD
Date   Source Headline
16th Apr 20247:00 amRNSPreliminary results for the year ended 31 Dec 2023
22nd Mar 20247:00 amRNSProposed disposal of RMSpumptools business
16th Feb 20244:30 pmRNSHolding(s) in Company
13th Feb 20245:52 pmRNSNotification of Major Holdings
13th Feb 20245:50 pmRNSHolding(s) in Company
8th Feb 20247:00 amRNSFull Year Trading Update
25th Jan 20247:00 amRNSAppointment of Independent Non-Executive Director
20th Dec 20236:06 pmRNSNotification of Director’s Interests in Shares
15th Dec 20233:07 pmRNSBLOCK LISTING SIX MONTHLY RETURN
22nd Nov 20234:06 pmRNSHolding(s) in Company
9th Nov 20231:59 pmRNSBoard Changes
26th Oct 20237:30 amRNSDirector Declaration
2nd Oct 20239:00 amRNSTotal Voting Rights and Share Capital
25th Sep 202311:29 amRNSDirector/PDMR Shareholding
21st Sep 20237:00 amRNSHalf year results
3rd Aug 20237:00 amRNSAppointment of Chief Financial Officer
17th Jul 20237:01 amRNSBoard Change
17th Jul 20237:00 amRNSHalf year trading update
6th Jul 20237:00 amRNSHolding(s) in Company
15th Jun 20233:18 pmRNSBLOCK LISTING SIX MONTHLY RETURN
14th Jun 20234:18 pmRNSResults of Annual General Meeting (“AGM”)
14th Jun 20237:00 amRNSAGM Trading Statement
12th Jun 20234:24 pmRNSNotification of Directors' Interests in Shares
9th Jun 20233:53 pmRNSNotification of Directors' Interest in Shares
7th Jun 20237:00 amRNSCompletion of refinancing
12th May 20234:49 pmRNSAnnual Report and Accounts 2022 and Notice of AGM
2nd May 20237:00 amRNSUpdate on full year results
28th Apr 20237:58 amRNSFull year results for the year ended 31 Dec 2022
26th Apr 20237:00 amRNSAgreed Revolving Credit Facility
28th Mar 20232:00 pmRNSHolding(s) in Company
24th Mar 20237:00 amRNSCorporate, Financing and Trading Update
6th Mar 20237:00 amRNSSale of JFN, Trading Update and Notice of Results
28th Dec 20227:00 amRNSSwordfish Dive Support Vessel sold for US$24m
19th Dec 20227:00 amRNSDisposal of three businesses
15th Dec 20224:30 pmRNSBLOCK LISTING SIX MONTHLY RETURN
19th Oct 20229:14 amRNSHolding(s) in Company
13th Sep 202212:59 pmRNSDirector/PDMR Shareholding
7th Sep 20227:00 amRNSHalf-year Report
1st Sep 20227:00 amRNSCompany Secretary Change
29th Jul 20224:39 pmRNSHolding(s) in Company
23rd Jun 20222:06 pmRNSHolding(s) in Company
17th Jun 20227:00 amRNSAppointment of Chief Executive Officer
15th Jun 20224:44 pmRNSBLOCK LISTING SIX MONTHLY RETURN
13th Jun 20227:00 amRNSCEO Update
6th May 20225:42 pmRNSHolding(s) in Company
5th May 20225:05 pmRNSResult of AGM
5th May 20227:00 amRNSAGM Trading Statement
25th Apr 20221:42 pmRNSDirector/PDMR Shareholding
30th Mar 20225:48 pmRNSAnnual Report and Notice of 2022 AGM posted
22nd Mar 20224:35 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.